The critical role of PI3K/AKT in SMO-independent activation of GLI is underlined by the finding that medulloblastoma cells resistant to SMOi display upregulation of PI3K/AKT signaling and sensitivity to PI3K targeting [70] (Figure 2B). The gene discussed is AKT1; the disease is medulloblastoma.